Masked Hypertension Clinical Trial
Official title:
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement (MASTER Study)
MASTER study is a 4-year prospective, randomized, open-label, blinded-endpoint study (PROBE) comparing 2 management strategies 1) office BP as a guide to treatment, or 2) 24-hour ABP as a guide to treatment. Study objectives are to investigate whether a management strategy based on out-of-office BP (Ambulatory BP monitoring) versus a management strategy based on office BP measurements is associated with differences in outcome, including cardiovascular and renal intermediate end points at one year; cardiovascular events at 4 years and changes in a number of blood pressure-related variables throughout the study. Patients will be followed-up during the first year focusing on changes in left ventricular mass index (LVMI, co-primary endpoint) and Urinary albumin excretion (UAE, albumin/creatinine ratio, co-primary end-point), and during the whole 48 month period for both changes in LVMI and UAE and events including all-cause mortality, CV morbidity and mortality, cerebral morbidity and mortality.A total of 1240 subjects will be recruited by 30 centers, taking into account a dropout rate of 15% (620 subjects per randomization arm).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02503943 -
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
|
Phase 4 | |
Recruiting |
NCT02156024 -
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
|
Phase 4 | |
Completed |
NCT02142881 -
Treatment of Masked Hypertension
|
Phase 3 | |
Active, not recruiting |
NCT04200716 -
Arterial Function After Two Different Physical Exercise Intensities in Prehypertension
|
N/A | |
Not yet recruiting |
NCT05409898 -
Screening for Masked Hypertension With Smart Wearable Devices (SMART)
|
||
Withdrawn |
NCT04121299 -
Mechanism of Masked Hypertension - Intervention
|
Phase 3 | |
Active, not recruiting |
NCT02893358 -
Antihypertensive Treatment in Masked Hypertension for Target Organ Protection
|
Phase 4 | |
Recruiting |
NCT02663336 -
Prevalence of Masked Hypertension in Nephrological Patients
|
||
Completed |
NCT04251975 -
Masked Hypertensive Patients With Obstructive Sleep Apnea
|
N/A |